<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00842296</url>
  </required_header>
  <id_info>
    <org_study_id>CLF-05-03</org_study_id>
    <nct_id>NCT00842296</nct_id>
  </id_info>
  <brief_title>ClosureFAST - Radiofrequency Great Saphenous Vein Treatment</brief_title>
  <official_title>ClosureFAST - Endovascular Radiofrequency Great Saphenous Vein Treatment Using a Catheter With an Integrated Heating Element</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to confirm that the ClosureFAST system can be used as an
      alternative to the current ClosurePlus catheter for treating the GSV and to accumulate
      pivotal data for optimization of the operating parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to confirm that the ClosureFAST system can be used as an
      alternative to the current ClosurePlus catheter for treating the GSV and to accumulate
      pivotal data for optimization of the operating parameters. The results from this study will
      be used to further evaluate the risks and benefits of the ClosureFAST device and to obtain
      clinical evidence that the treatment provides effective and durable clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>6 Months</time_frame>
    <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up Duplex Ultrasound (DU) scan. Flow which originates in the Saphenofemoral Junction (SFJ) and which measures &lt; 3 cm in length, does not constitute a failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>12 months</time_frame>
    <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>2 years</time_frame>
    <description>Vein occlusion is defined as the absence of flow in the treated vein as documented on the post-procedure and each successive follow-up DU scan.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>3 years</time_frame>
    <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>4 years</time_frame>
    <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Vein Occlusion</measure>
    <time_frame>5 years</time_frame>
    <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>6 months</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>12 months</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>2 years</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>3 years</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>4 years</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Limbs Without Reflux in the Treated Vein Segment</measure>
    <time_frame>5 years</time_frame>
    <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CEAP (Clinical, Etiologic, Anatomic, and Pathophysiologic) Classification</measure>
    <time_frame>Baseline</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at baseline. The CEAP clinical Categories are as follows where C1 is of the least clinical concern and C6 is the worst stage; C1- Reticular and spider veins C2- Varicose veins C3- Varicose veins and leg swelling C4- Varicose veins and evidence of venous stasis skin changes C5- Varicose veins and a healed venous stasis ulceration C6- Varicose veins and an open venous ulceration
Reference: Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: The &quot;CEAP&quot; classification. Mayo Clinic Proc 1996;71:338-45.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CEAP Classification</measure>
    <time_frame>1 Week</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CEAP Classification</measure>
    <time_frame>3 months</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CEAP Classification</measure>
    <time_frame>12 months</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CEAP Classification</measure>
    <time_frame>5 years</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Venous Clinical Severity Score (VCSS) From Baseline to 5Y Follow-up</measure>
    <time_frame>Baseline thru 5 years</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VCSS Status from Baseline to 5 years. VCSS assesses 10 factors of venous disease whereby each factor is graded on a severity scale of 0-3 (least to worst). The higher the VCSS score the most severe the clinical signs and symptoms of venous disease are in a patient. VCSS improvement over time is presented by a decrease in VCSS total score (maximum score = 30; minimum score = 0).
Reference: Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Scale (VAS)</measure>
    <time_frame>5 years</time_frame>
    <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VAS for pain scored from 0-10 with 10 being worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Complications From Greater Saphenous Vein (GSV) Intervention</measure>
    <time_frame>1 Week</time_frame>
    <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Complications From GSV Intervention</measure>
    <time_frame>3 Months</time_frame>
    <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Complications From GSV Intervention</measure>
    <time_frame>12 months</time_frame>
    <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Complications From GSV Intervention</measure>
    <time_frame>5 years</time_frame>
    <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">326</enrollment>
  <condition>Venous Reflux</condition>
  <arm_group>
    <arm_group_label>Seg. RF Ablation with CLF catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single Arm with CLF Catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF ablation (ClosureFAST)</intervention_name>
    <description>Segmental RF Ablation with the CLF catheter</description>
    <arm_group_label>Seg. RF Ablation with CLF catheter</arm_group_label>
    <other_name>CLF</other_name>
    <other_name>CLosureFAST</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 80 years of age at the time of enrollment

          -  Symptomatic lower limb venous disease involving the GSV

        Exclusion Criteria:

          -  Thrombosis in the vein segment to be treated

          -  Known or suspected pregnancy or actively breast feeding at time of treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa Hasenbank, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic</affiliation>
  </overall_official>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2009</study_first_submitted>
  <study_first_submitted_qc>February 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2009</study_first_posted>
  <results_first_submitted>June 26, 2017</results_first_submitted>
  <results_first_submitted_qc>November 7, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 11, 2017</results_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GSV</keyword>
  <keyword>RadioFrequency</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment from April 24, 2006- September 5, 2006. Medical offices/clinics and university hospital.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
          <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="326"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="326"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>326 patients were enrolled and 396 limbs were treated and are analyzed. Only 395 limbs provided baseline CEAP data.</population>
      <group_list>
        <group group_id="B1">
          <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
          <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="326"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>limbs</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="396"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.8" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CEAP</title>
          <description>CEAP (Clinical/Etiology/Anatomy/Pathophysiology) Clinical Score:
C0: No visible/palpable sign C1: Reticular spider veins C2: Simple varicose veins C3: Ankle edema C4: Skin pigmentation C5: Healed venous ulcer C6: Open venous ulcer
395 out of 396 limbs reported a Baseline CEAP score.</description>
          <population>only 395 out of 396 limbs reported a Baseline CEAP score</population>
          <units>limbs</units>
          <param>Number</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="395"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up Duplex Ultrasound (DU) scan. Flow which originates in the Saphenofemoral Junction (SFJ) and which measures &lt; 3 cm in length, does not constitute a failure.</description>
        <time_frame>6 Months</time_frame>
        <population>363 limbs were available for primary outcome measure evaluation at the 6M timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up Duplex Ultrasound (DU) scan. Flow which originates in the Saphenofemoral Junction (SFJ) and which measures &lt; 3 cm in length, does not constitute a failure.</description>
          <population>363 limbs were available for primary outcome measure evaluation at the 6M timepoint.</population>
          <units>percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="293"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="363"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
        <time_frame>12 months</time_frame>
        <population>350 limbs were evaluated at the 12M timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
          <population>350 limbs were evaluated at the 12M timepoint</population>
          <units>percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.6" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Vein occlusion is defined as the absence of flow in the treated vein as documented on the post-procedure and each successive follow-up DU scan.</description>
        <time_frame>2 years</time_frame>
        <population>Out of the limbs treated 329 limbs were available for a Duplex Ultrasound scan at the 2Y follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Vein occlusion is defined as the absence of flow in the treated vein as documented on the post-procedure and each successive follow-up DU scan.</description>
          <population>Out of the limbs treated 329 limbs were available for a Duplex Ultrasound scan at the 2Y follow-up</population>
          <units>percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="263"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.3" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
        <time_frame>3 years</time_frame>
        <population>293 limbs were evaluated at the 3Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
          <population>293 limbs were evaluated at the 3Y timepoint</population>
          <units>percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="293"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
        <time_frame>4 years</time_frame>
        <population>275 limbs were evaluated at the 4Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
          <population>275 limbs were evaluated at the 4Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="210"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Vein Occlusion</title>
        <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
        <time_frame>5 years</time_frame>
        <population>279 limbs were evaluated at the 5Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Vein Occlusion</title>
          <description>Defined as the absence of flow in the treated vein as documented on the post-procedure and follow-up DU scan. Flow which originates in the SFJ and which measures &lt; 3 cm in length, does not constitute a failure.</description>
          <population>279 limbs were evaluated at the 5Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.0" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>6 months</time_frame>
        <population>363 limbs were evaluated at the 6M timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>363 limbs were evaluated at the 6M timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="293"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="363"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.5" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>12 months</time_frame>
        <population>350 limbs were evaluated at the 12M timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>350 limbs were evaluated at the 12M timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.9" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>2 years</time_frame>
        <population>329 limbs were evaluated at the 2Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>329 limbs were evaluated at the 2Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="263"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>3 years</time_frame>
        <population>293 limbs were evaluated at the 3Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>293 limbs were evaluated at the 3Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="293"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>4 years</time_frame>
        <population>275 limbs were evaluated at the 4Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>275 limbs were evaluated at the 4Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="210"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
        <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
        <time_frame>5 years</time_frame>
        <population>279 limbs were evaluated at the 5Y timepoint</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Limbs Without Reflux in the Treated Vein Segment</title>
          <description>No reflux in the vein segment treated. Reflux was defined as reversal flow &gt;0.5s with subject standing or in reverse Trendelenburg position of at least 15° after distal augmentation.</description>
          <population>279 limbs were evaluated at the 5Y timepoint</population>
          <units>Percentage of limbs</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CEAP (Clinical, Etiologic, Anatomic, and Pathophysiologic) Classification</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at baseline. The CEAP clinical Categories are as follows where C1 is of the least clinical concern and C6 is the worst stage; C1- Reticular and spider veins C2- Varicose veins C3- Varicose veins and leg swelling C4- Varicose veins and evidence of venous stasis skin changes C5- Varicose veins and a healed venous stasis ulceration C6- Varicose veins and an open venous ulceration
Reference: Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: The “CEAP” classification. Mayo Clinic Proc 1996;71:338-45.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>CEAP (Clinical, Etiologic, Anatomic, and Pathophysiologic) Classification</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at baseline. The CEAP clinical Categories are as follows where C1 is of the least clinical concern and C6 is the worst stage; C1- Reticular and spider veins C2- Varicose veins C3- Varicose veins and leg swelling C4- Varicose veins and evidence of venous stasis skin changes C5- Varicose veins and a healed venous stasis ulceration C6- Varicose veins and an open venous ulceration
Reference: Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: The “CEAP” classification. Mayo Clinic Proc 1996;71:338-45.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="395"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CEAP Classification</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
        <time_frame>1 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>CEAP Classification</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="395"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>C0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="180"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C6</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CEAP Classification</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
        <time_frame>3 months</time_frame>
        <population>Only 302 subjects (371 limbs) completed the 3 Month follow-up visit to provide data to this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>CEAP Classification</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
          <population>Only 302 subjects (371 limbs) completed the 3 Month follow-up visit to provide data to this outcome measure.</population>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="302"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="371"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>C0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C6</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CEAP Classification</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
        <time_frame>12 months</time_frame>
        <population>Only 280 subjects (350 limbs) completed the 12 Month follow-up visit to provide data to this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>CEAP Classification</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
          <population>Only 280 subjects (350 limbs) completed the 12 Month follow-up visit to provide data to this outcome measure.</population>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>C0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="194"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C6</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CEAP Classification</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
        <time_frame>5 years</time_frame>
        <population>Only 221 subjects (279 limbs) completed the 5 Year follow-up visit to provide data to this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>CEAP Classification</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease as measured by CEAP Classification at follow-up where C1 is the best and C6 is the worst in terms of clinical status.</description>
          <population>Only 221 subjects (279 limbs) completed the 5 Year follow-up visit to provide data to this outcome measure.</population>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>C0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>C6</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Venous Clinical Severity Score (VCSS) From Baseline to 5Y Follow-up</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VCSS Status from Baseline to 5 years. VCSS assesses 10 factors of venous disease whereby each factor is graded on a severity scale of 0-3 (least to worst). The higher the VCSS score the most severe the clinical signs and symptoms of venous disease are in a patient. VCSS improvement over time is presented by a decrease in VCSS total score (maximum score = 30; minimum score = 0).
Reference: Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.</description>
        <time_frame>Baseline thru 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Venous Clinical Severity Score (VCSS) From Baseline to 5Y Follow-up</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VCSS Status from Baseline to 5 years. VCSS assesses 10 factors of venous disease whereby each factor is graded on a severity scale of 0-3 (least to worst). The higher the VCSS score the most severe the clinical signs and symptoms of venous disease are in a patient. VCSS improvement over time is presented by a decrease in VCSS total score (maximum score = 30; minimum score = 0).
Reference: Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.</description>
          <units>VCSS Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Pain Scale (VAS)</title>
        <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VAS for pain scored from 0-10 with 10 being worst possible pain</description>
        <time_frame>5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Pain Scale (VAS)</title>
          <description>Status of clinical signs and symptoms of lower limb venous disease evaluated using standardized scales and subject responses to post-procedure standardized questions - VAS for pain scored from 0-10 with 10 being worst possible pain</description>
          <units>units on a scale (0-10)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="395"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Complications From Greater Saphenous Vein (GSV) Intervention</title>
        <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
        <time_frame>1 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Complications From Greater Saphenous Vein (GSV) Intervention</title>
          <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="395"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ecchymosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Pigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thermal Skin Injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombus Extension / DVT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Complications From GSV Intervention</title>
        <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
        <time_frame>3 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Complications From GSV Intervention</title>
          <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="371"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ecchymosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Pigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thermal Skin Injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombus Extension / DVT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Complications From GSV Intervention</title>
        <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Complications From GSV Intervention</title>
          <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ecchymosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Pigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thermal Skin Injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombus Extension / DVT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Complications From GSV Intervention</title>
        <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
        <time_frame>5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
            <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Complications From GSV Intervention</title>
          <description>Number of limbs that presented with the listed complications and side effects resulting from the GSV intervention.</description>
          <units>limbs</units>
          <param>Count of Units</param>
          <units_analyzed>limbs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="326"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>limbs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ecchymosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Pigmentation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thermal Skin Injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombus Extension / DVT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 years</time_frame>
      <desc>SAEs were collected through study closure at 5 years. An SAE was defined as any AE that led to death, to a serious deterioration in the health of a subject that resulted in a life-threatening injury, a permanent impairment of a body structure/body function, hospitalization or prolongation of existing hospitalization, in a medical or surgical intervention to prevent permanent impairment of body structures or a body function; or led to fetal distress, fetal death, or a congenital birth defect.</desc>
      <group_list>
        <group group_id="E1">
          <title>ClosureFAST® - Endovascular Radiofrequency Great Saphenous Vei</title>
          <description>Single Arm with ClosureFAST (CLF) Catheter with an integrated healing element. Radiofrequency (RF) ablation (ClosureFAST): Segmental RF Ablation with the CLF catheter</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>GI Bleed</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>GI Bleed</sub_title>
                <description>Unrelated event, Fatal GI Bleed</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death (Unknown Cause)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title vocab="Thrombus extension">Thrombus extensions</sub_title>
                <description>Thrombus extensions into the Common Femoral vein (CFV)</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title vocab="Pulmonary Emboli">Pulmonary Emboli (PE)</sub_title>
                <description>Pulmonary Emboli (PE)</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephanie Brucato, Principal Clinical Research Specialist</name_or_title>
      <organization>Medtronic</organization>
      <phone>508-261-8000</phone>
      <email>stephanie.m.brucato@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

